Skip to main content

Table 1 Patient characteristics of ICU survivors. Comparison between ICU survivors who completed the SF-36 form and those who did not

From: Long-term health-related quality of life of critically ill patients with haematological malignancies: a prospective observational multicenter study

Variables Hospital survivors n (%) or median (IQR) Patients who did not complete the SF-36 form at 3 months n (%) or median (IQR) Patients who completed the SF-36 form at 3 months n (%) or median (IQR) p
N 616 338 (55) 278 (45)  
Male 252 (41) 139 (41) 113 (41) 0.87
Age 59 (47; 68) 60 (47; 71) 58 (47; 65) 0.020
Performance status     
 0–2 529 (86) 286 (85) 243 (87)  
 3–4 85 (14) 50 (15) 35 (13)  
Charlson index 4 (2;5) 4 (2; 6) 4 (2; 5) 0.024
Malignancies     0.68
 AML 162 (26) 82 (24) 80 (29)  
 Non-Hodgkin’s lymphoma 191 (31) 111 (33) 80 (29)  
 Hodgkin’s lymphoma 18 (3) 9 (3) 9 (3)  
 ALL 44 (7) 22 (7) 22 (8)  
 CLL 45 (7) 24 (7) 21 (8)  
 CML 14 (2) 10 (3) 4 (1)  
 Myeloma 86 (14) 51 (15) 35 (13)  
 Myelodysplastic syndrome 26 (4) 14 (4) 12 (4)  
BMT/HSCT recipient     0.024
 Autologous 78 (13) 37 (11) 41 (15)  
 Allogeneic 70 (11) 30 (9) 40 (14)  
Disease status at admission     0.16
 Newly diagnosed 237 (41) 135 (42) 102 (39)  
 Partial remission 46 (8) 23 (7) 23 (9)  
 Complete remission 111 (19) 52 (16) 58 (23)  
SOFA score 5 (3; 7) 5 (3; 7) 5 (3; 7) 0.67
Mechanical ventilation 190 (31) 111 (33) 79 (28) 0.22
Vasopressors 219 (36) 111 (33) 100 (36) 0.93
Renal replacement therapy 106 (18) 68 (21) 38 (14) 0.025
Sedation 177 (29) 100 (30) 77 (28) 0.59
ICU LOS (days) 6 (3;10) 6 (4; 10) 5 (3; 10) 0.24
  1. MDS myelodysplastic syndrome, AML acute myeloid leukaemia, ALL acute lymphocytic leukaemia, CLL chronic lymphocytic leukaemia, CML chronic myeloid leukaemia, BMT bone marrow transplantation, HSC haematopoietic stem cell transplant, SOFA sepsis-related organ failure assessment, ICU intensive care unit, LOS length of stay